Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases

Annals of Surgical Oncology

Volumn 15, Issue 1, 2008, Pages 207-218

  O'Rourke, Thomas R ^a,b   Tekkis, Paris ^c   Yeung, Shinn ^b   Fawcett, Jonathan ^b   Lynch, Stephen ^b   Strong, Russell ^b   Wall, Daryl ^b   John, Timothy G ^a   Welsh, Fenella ^a   Rees, Myrddin ^a  

^a BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Hepatectomy; Non colorectal; Non neuroendocrine metastases

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER SURVIVAL; DEMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; HAZARD RATIO; HUMAN; INFORMATION PROCESSING; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; SURGICAL MORTALITY; SURVIVAL; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; UROGENITAL NEOPLASMS;

EID: 38049112521     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9649-4     Document Type: Article

References (39)

1. Brunschwig A, Morton DR. Resection of abdominal carcinomas involving the liver and spleen secondarily. Ann Surg 1946; 124:746-54
2. Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978; 135:389-94
3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19:59-71
4. Rees M, Plant G, Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997; 84:1136-40
5. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230:309-18
6. Sutcliffe R, Maguire D, Ramage J, et al. Management of neuroendocrine liver metastases. Am J Surg 2004; 187:39-46
7. Sarmiento JM, Que FG. Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin North Am 2003; 12:231-42
8. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival. J Am Coll Surg 2003; 197:29-37
9. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: Analysis of 1,452 patients and development of a prognostic model. Ann Surg 2006; 244:524-35
10. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002; 94:2511-6
11. Rees M, Plant G, Wells J, Bygrave S. One hundred and fifty hepatic resections:evolution of technique towards bloodless surgery. Br J Surg 1996; 83:1526-9
12. Shaw IM, Rees M, Welsh FKS, Bygrave S, John TG. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg 2006; 93:457-64
13. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. A prospective evaluation of long-term survival following hepatic resection for metastatic colorectal cancer - a multifactorial model of 929 patients. Ann Surg (in press)
14. Couinaud C. Le Foie: Études Anatomiques et Chirurgicales. Masson, Paris, 1957
15. Strasberg SM, Belghiti J, Clavien PA, Gadzijev E, Garden OJ, Lau WY, et al. Terminology of liver anatomy and resections. HPB 2000; 2:333-9
16. Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, D'Angelica M, et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 2006; 244:260-4
17. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: A contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004; 240:1052-61
18. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 2004; 240:644-57
19. Charfare H, Limongelli S, Purushotham AD. Neoadjuvant chemotherapy in breast cancer. Br J Surg 2005; 92:14-23
20. Lordick F, Stein HJ, Peschel C, Siewert JR. Neoadjuvant therapy for oesophagogastric cancer. Br J Surg 2004; 91:540-51
21. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004; 240:438-50
22. Fong Y, Saldinger PF, Akhurst T, Macapinlac H, Yeung H, Finn RD, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999; 178:282-7
23. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis. Radiology 2002; 224:748-56
24. Kurli M, Reddy S, Tena LB, Pavlick AC. Finger PT. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma. Am J Ophthalmol 2005; 140:193-9
25. D'Angelica M, Jarnagin W, Dematteo R, Conlon K, Blumgart LH, Fong Y. Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases. Ann Surg Oncol 2002; 9:204-9
26. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 2006; 244:897-907
27. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M, et al. Resection of liver metastases from a noncolorectal primary: Indications and results based on 147 monocentric patients. J Am Coll Surg 1998; 187:487-93
28. Yedibela S, Gohl J, Graz V, Pfaffenberger MK, Merkel S, Hohenberger W, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: A single-institutional review. Ann Surg Oncol 2005; 12:778-85
29. Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D'Angelica M, Harrison LE, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 2005; 241:269-276
30. Harrison LE, Brennan MF, Newman E, Fortner JG, Picardo A, Blumgart LH, et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: A fifteen-year experience with ninety-six patients. Surgery. 1997; 121:625-32
31. Ercolani G, Grazi GL, Ravaioli M, Ramacciato G, Cescon M, Varotti G, et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: Experience with 142 observed cases. Ann Surg Oncol 2005; 12:459-66
32. Karavias DD, Tepetes K, Karatzas T, Felekouras E, Androulakis J. Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol 2002; 28:135-9
33. Earle SA, Perez EA, Gutierrez JC, Sleeman D, Livingstone AS, Franceschi D, et al. Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg 2006; 203:436-46
34. Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 2003; 12:165-92
35. Pawlik TM, Zorzi D, Abdalla EK, Clary BM, Gershenwald JE, Ross MI, et al. Hepatic resection for metastatic melanoma: Distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 2006; 13:712-20
36. Pawlik TM, Vauthey JN, Abdalla EK, Pollock RE, Ellis LM, Curley SA. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 2006; 141:537-43
37. DeMatteo RP, Maki RG, Singer S, Gonen M, Brennan MF, Antonescu CR. Results of Tyrosine Kinase Inhibitor Therapy Followed by Surgical Resection for Metastatic Gastrointestinal Stromal Tumor. Ann Surg 2007; 245:347-52
38. Gronchi A, Fiore M, Miselli F, Lagonigro MS, Coco P, Messina A, et al. Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST. Ann Surg 2007; 245:341-6
39. Metcalfe MS, Mullin EJ, Maddern GJ. Hepatectomy for metastatic noncolorectal gastrointestinal, breast and testicular tumours. ANZ J Surg 2006; 76:246-50